American Journal of Endocannabinoid Medicine - Ownership and Business Overview

PublishingCompany

American Journal of Endocannabinoid Medicine Ownership

Who owns American Journal of Endocannabinoid Medicine?

American Journal of Endocannabinoid Medicine is owned by Haymarket Medical Network. It was acquired on March 9, 2023.

American Journal of Endocannabinoid Medicine Business Overview

Where is American Journal of Endocannabinoid Medicine headquartered?

American Journal of Endocannabinoid Medicine is headquartered in Woodland Park, New Jersey.

What sector is American Journal of Endocannabinoid Medicine in?

American Journal of Endocannabinoid Medicine is a publishing company.

Publishing M&A Summary in 2023

Out of 60 sectors in the Mergr database, publishing ranked 52 in number of deals in 2023. The largest publishing acquisition in 2023 was Simon & Schuster - which was acquired by KKR for $1.6B.

Join Mergr to view all 22 acquisitions of publishing companies in 2023, including 4 acquisitions by private equity firms, and 18 by strategics.

American Journal of Endocannabinoid Medicine

American Journal of Endocannabinoid Medicine

Woodland Park, New Jersey 07424
United States,
www.ajendomed.com

American Journal of Endocannabinoid Medicine (AJEM) publishes peer-reviewed research on the endocannabinoid system (ECS) and the practice of evidence-based cannabinoid medicine. As the first and only American medical authority to explore the ECS as a therapeutic target, AJEM seeks to educate medical professionals by providing high-quality, peer-reviewed research, expert commentary, as well as articles on cannabis-related news and policy issues. American Journal of Endocannabinoid Medicine is based in Woodland Park, New Jersey.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.